BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
48 hedge funds and large institutions have $4.09M invested in BRAINSTORM CELL THERAPUTC in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 47 → 48 (+1)
0.61% more ownership
Funds ownership: 0.55% → 1.16% (+0.61%)
Holders
48
Holding in Top 10
–
Calls
$72K
Puts
$43K
Top Buyers
| 1 | +$2.68M | |
| 2 | +$43.1K | |
| 3 | +$37.1K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$34.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$25.6K |
Top Sellers
| 1 | -$63K | |
| 2 | -$45.8K | |
| 3 | -$34.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 5 |
SFG
Socha Financial Group
Corning,
New York
|
-$6.99K |